WO2008096894A1 - セルロース誘導体およびその製造方法 - Google Patents
セルロース誘導体およびその製造方法 Download PDFInfo
- Publication number
- WO2008096894A1 WO2008096894A1 PCT/JP2008/052382 JP2008052382W WO2008096894A1 WO 2008096894 A1 WO2008096894 A1 WO 2008096894A1 JP 2008052382 W JP2008052382 W JP 2008052382W WO 2008096894 A1 WO2008096894 A1 WO 2008096894A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cellulose derivative
- cellulose
- water
- adhesion
- gel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/02—Alkyl or cycloalkyl ethers
- C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
- C08B11/14—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals with nitrogen-containing groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/02—Alkyl or cycloalkyl ethers
- C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
- C08B11/10—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals
- C08B11/12—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals substituted with carboxylic radicals, e.g. carboxymethylcellulose [CMC]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/02—Alkyl or cycloalkyl ethers
- C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
- C08B11/14—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals with nitrogen-containing groups
- C08B11/145—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals with nitrogen-containing groups with basic nitrogen, e.g. aminoalkyl ethers
Definitions
- the present invention relates to a cellulose derivative having a specific structure, a composition comprising a cellulose derivative having a specific structure and a phospholipid, an Sjg method thereof, and an adhesion-preventing material comprising the derivative or compound.
- anti-adhesion materials using water of carboxymethylcellulose ⁇ m J S ur g., 1 69, 1 5 4-1 5 9 (1 9 9 5).
- this anti-adhesion material has low retention in the body and cannot fully exert the anti-adhesion effect. For this reason, attempts have been made to modify polysaccharides by various methods and insolubilize 7K ⁇ ).
- an anti-adhesion material in which hyaluronic acid and carboxymethyl cellulose are modified with calpositimide has been proposed (International Publication WO 9 2/0 0 0 1 0 5 Panflate, International Publication WO 9 2Z 0 2 0 3 4 9 Pamphlet )
- an anti-adhesion material having as a main component a cellulose derivative in which a hydrogen atom of cellulose is substituted with a specific converting group has been proposed (Japanese Patent Laid-Open No. Hei 1 30 16 2 4).
- an anti-adhesion material comprising a hyaluronic acid compound modified with phosphatidylethanolamine has been proposed (Japanese Patent Laid-Open No. 2000-0629 No. 6).
- U.S. Patent No. 5 0 6 4 8 1 7 Pat is a carboxymethylcellulose and the phosphatidyl ethanolate one Ruamin reacted in an aqueous solvent to obtain a phospholipase A 2 inhibitor compositions reactions are described. However, as shown in the key ratio 5, it is known that the target compound is not formed under this reaction condition.
- Panfurez is a water-insoluble organism comprising reacting a polyanionic polysaccharide with an active agent in an aqueous solution containing a water-compatible organic solvent. Suitable gels are described, and carboxymethyl cellulose is listed as a polyanionic polysaccharide.
- Japanese Patent Application Laid-Open No. 9-296005 discloses that when a modifying group comprising a hydrophobic group is introduced into a polysaccharide, the viscosity is increased and the in vivo stability is improved without gelling the polysaccharide. It is described that it can be achieved. However, there is no description or suggestion of a cellulose derivative useful for obtaining the adhesion preventing effect of the present invention and a fiber comprising the same. Disclosure of the invention
- An object of the present invention is to provide a cellulose derivative useful as a medical material or a composition comprising the same.
- a cellulose derivative useful as a medical material or a composition comprising the same when it is made into a hide-mouthed gel, it has an appropriate elastic modulus and viscoelasticity, and provides a cellulose derivative useful as an adhesion-preventing material or a composition comprising the same, particularly excellent in retention in the body.
- the object is to provide a gel-like adhesion-preventing material.
- an object of the present invention is to provide a method for producing the cellulose derivative or a composition comprising the cellulose derivative.
- the present inventors modify cellulose with a material having excellent safety, increase viscoelasticity, improve retention in vivo, have high viscoelasticity, and improve adhesion prevention effect. I studied about it.
- the present inventors replaced the side chain with phosphatidylethanolamine, which is a biological agent, for the hydrogen atom of Carpoxymethylcellulose, which has moderate viscoelasticity, is useful as an anti-adhesion material, and is a syringe. It has been found that a new leululose derivative 3 ⁇ 4 # can be obtained which can form a hyde mouth gel that can be injected through. The present inventors have further found that a cellulose derivative having an appropriate viscoelasticity and useful as an adhesion preventing material can be obtained by allowing a specific amount of phospholipid to coexist with the cellulose derivative. That is, the present invention is a cellulose incentive consisting of a repeating unit represented by the following formula. In the formula, RR 2 and R 3 are each independently selected from the following formulas (a), (c), and (d):
- X is an alkali metal or alkaline earth metal
- R 4 and R 5 are each independently an alkyl group or alkenyl group having 9 to 27 carbon atoms
- the total degree of substitution of (b) and (c) is 0.3 to 2.0
- the position of (d) is 0 ⁇ 001 ⁇ 0.05.
- the present invention also includes a phospholipid represented by the following formula, and the ratio of the molar equivalent of the cell mouth-reducing unit to the molar equivalent of the phospholipid is from 1: 0.05 to: I: A cellulose derivative composition which is 1.
- R 6 and R 7 are each independently an alkyl group or alkenyl group having 9 to 27 carbon atoms, and R 8 is one NH 3 + or one N (CH 3 ) 3 +.
- the present invention comprises a repeating unit represented by the following formula, and an amount of carboxymethylcellulose of 5 ⁇ 10 3 to 5 ⁇ 10 6,
- a phosphatidylethanolamine represented by the following formula:
- It consists of water and organics compatible with water at a ratio of phosphatidylethanolamine 0.1 to 10 equivalents to 100 equivalents of carboxyl groups of carboxymethylcellulose. It is a method for producing a cellulose derivative of the present invention, which comprises a step of dissolving in 0% by volume of mixed soot and reacting under a condensing agent.
- R 1, R 2 , and R 3 are each independently selected from the following formulas (a), (b), and (c): -H (a)
- X is an alkali metal or an alkaline earth metal
- R 4 and R 5 are each independently an alkyl group or alkenyl group having 9 to 27 carbon atoms.
- the cellulose derivative obtained by the above-described method (g) and a phospholipid represented by the following formula are mixed using water and a mixed solvent containing water and an organic compound compatible with water, and then the solvent is added. It is a manufacturing method of an above-mentioned cellulose derivative composition which comprises the process to remove.
- R 6 and R 7 are each independently an alkyl group or alkenyl group having 9 to 27 carbon atoms, and R 8 is one NH 3 + or one N (CH 3 ) 3 +.
- the present invention is an adhesion preventing material containing the above-described cellulose derivative or cellulose derivative composition.
- the present invention is an axable hide-mouthed gel containing 0.1 to 1.5 parts by weight of the above cellulose derivative with respect to 100 parts by weight of water.
- the cellulose derivative composition described above is added to 100 parts by weight of water. ⁇ 5.0 parts by weight, & ⁇ -capable hyde mouth gel.
- the cellulose derivative of the present invention forms a hydrogel having an appropriate elastic modulus and viscoelasticity, is colorless and transparent, has sufficient viscoelasticity to form a gel even at a low concentration, and has a capillary such as a syringe. It is possible to inject using a device. According to the Sit method of the present invention, powerful cellulose attraction #: can be made efficient.
- the cellulose derivative composition of the present invention also forms a hydrogel having an appropriate elastic modulus and viscoelasticity when dissolved in water, and can be used as a medical injection burgundy preventing material.
- the cellulose derivative composition of the present invention is safe because it contains phosphatidylethanolamines or phosphatidylcholines as biological substances.
- the cellulose derivative composition of the present invention has an appropriate elastic modulus and viscosity by applying free H phosphatidylethanolamines or phosphatidylcholines to the cellulose derivative # substituted with phosphatidylethanolamine.
- An elastic hydrogel can be formed According to the production method of the present invention, such a cellulose derivative composition can be produced efficiently.
- the anti-adhesion material of the present invention is excellent in retention in the body and excellent in the anti-adhesion effect.
- the gel-like anti-adhesion material of the present invention has sufficient flexibility and viscoelasticity, is easy to handle, can be applied to complicated ⁇ K sites, and is also applicable to surgery using an endoscope. Is possible.
- FIG. 1 is a schematic diagram showing the coating of fibronectin across the body.
- the present invention is a cellulose derivative composed of a repeating unit represented by the following formula.
- RR 2 and R 3 are each independently represented by the following formulas (a), (b), (c), and
- X is an alkaline pan or alkaline earth ⁇
- R 4 and R 5 are each independently an alkyl group or alkenyl group having 9 to 27 carbon atoms
- the total substitution degree of (b) and (c) is 0.3 to 2.0
- alkali metal of carb X sodium, potassium, lithium and the like are preferable, and as the alkaline earth metal, magnesium, calcium and the like are preferable.
- R 4 and R 5 are each preferably an alkenyl group having 9 to 19 carbon atoms. Of these, R 4 CO—and / or R 5 CO—power oil bases are preferred, especially R 4 CO— and R 5 CO—power oil bases.
- the sum of (b) and (c) is 0.3 to 2.0, preferably 0.5 to 1.8, and more preferably 0.6 to 1.5.
- the ratio of (b) and (c) is not particularly limited, but from the viewpoint of solubility in water, (c) more than force (b) is preferable.
- the degree of substitution of (d) is 0.001 to 0.05, preferably 0.005 to 0.03.
- the position m3 ⁇ 4 of (d) is obtained by quantitative analysis of phosphorus by elemental analysis.
- cellulose derivatives should be After hydrolysis with a basic aqueous solution, the analysis of mrn ⁇ Ipc, etc. can be used by coloring the phosphorous ions such as the phosphorus-molybdenum method.
- preferred weight average liver weight of the cellulose ⁇ of the present invention is 5 X 1 0 3 ⁇ 5 X 1 0 6, more preferably 5 X 1 0 4 ⁇ 5 X 1 0 6, more preferably 5 X 1 0 4 to 1 X 1 0 6 .
- Weight average of cellulose derivative; ⁇ amount increases by the introduction of the group represented by the formula (d), so that a cellulose derivative having a target molecular weight can be obtained by appropriately selecting the molecular weight of carboxymethyl cellulose as a raw material. Can do.
- the present invention includes the cellulose derivative described above and a phospholipid represented by the following formula, wherein the ratio of the molar equivalent of the repeating unit of the cellulose derivative to the molar equivalent of the phospholipid is from 1: 0.05 to 1: 1.
- a cellulose derivative composition
- R 6 and R 7 are each independently an alkyl group or alkenyl group having 9 to 27 carbon atoms, and R 8 is one NH 3 + or one N (CH 3 ) 3 +.
- cellulose derivative as a constituent component of the cellulose derivative composition of the present invention, those described above as preferred for the cell ⁇ -derivative of the present invention are used appropriately.
- R 4 and R 5 in formula (d) are preferably all alkenyl groups having 9 to 19 carbon atoms, and in particular, those in which R 4 CO— and Z or R 5 CO— are oleoyl groups. Particularly preferred are those in which R 4 CO— and R 5 C 0— are oleoyl groups.
- R 6 and R 7 in the phospholipid represented by the above formula both are preferably alkenyl groups having 9 to carbon atoms: I 9, particularly R 6 CO— and Z or R 7 CO— Les Oil bases are preferred, especially R 6 C 0— and R 7 CO—strength oil bases.
- R 8 is one NH 3 +
- R 4 , R 5 , R 6 , and R 7 are all the same, and among them, R 4 C 0 1, R 5 CO—, R 6 Both CO— and R 7 CO— are preferably oleoyl groups, and at the same time, R 8 is —NH 3 + .
- the cellulose derivative of the present invention described above consists of a repeating unit represented by the following formula, and has a liver capacity of 5 ⁇ 10 3 to 5 ⁇ 10 6 carboxymethylcellulose,
- a phosphatidylethanolamine represented by the following formula:
- Carboxymethylcellulose carboxyl group (ie, total of (b) + (c) substituents) 100 equivalents of phosphatidylethanolamine 0.1 to 100 equivalents of water and organic phase compatible with water It can be obtained by a method comprising a step of dissolving in a mixture containing 20 to 70% by volume of water and reacting in the presence of a condensing agent.
- R ′, R 2 , and R 3 are each independently selected from the following formulas (a), (b), and (c): -H (a)
- X is an alkaline pot or alkaline earth pot
- R 4 and R 5 are each independently an alkyl group or alkenyl group having 9 to 27 carbon atoms.
- Cal port carboxymethyl cellulose as such a raw material is preferably a molecular weight of 5 X 10 3 ⁇ 5 X 10 6 , more preferably 5X 10 4 ⁇ 5X 10 6, even more preferably 5X 10 4 ⁇ 1X10 6.
- Carboxymethyl cellulose as such a raw material can be migrated by, for example, dissolving pulp with sodium hydroxide solution, etherifying with monochloroacetic acid or its sodium salt, and purifying.
- alkali metal of X in the above formula (c) sodium, potassium, lithium and the like are preferable, and as the alkaline earth, magnesium, calcium and the like are preferable.
- the total degree of substitution of (b) and (c) is 0.3 to 2.0, preferably 0.5 to 1.8, more preferably 0.6 to 1.5.
- the ratio of (b) and (c) is limited, but from the viewpoint of solubility in water, (c) force (b) is much more vigorous than T (b).
- the specific structural formula of recarboxymethyl cellulose preferred as a raw material is as shown in the following formula.
- the substitution position of the carboxymethyl group in the cellulose skeleton should be at the C-6 position.
- R 4 and R 5 are each independently an alkyl group having 9 to 27 carbon atoms. Or an alkenyl group.
- R 4 and R 5 are each preferably an alkenyl group having 9 to 27 carbon atoms, more preferably an R 4 CO— and / or R 5 CO-force oleoylile group, particularly R 4 CO— and R 5 CO—Power 3 ⁇ 4 What is the Leoyl group?
- phosphatidylethanolamine can be used either extracted from animal fiber or synthesized and migrated.
- the phosphatidylethanolamine include dilauroyl phosphatidylethanolamine, dimyristoyl phosphatidylethanolamine, dipalmitoyl phosphatidylethanolamine, distearoylphosphatidylethanolamine, diarachidoylphosphatidylethanolamine, dibeheno Ilphosphatidylethanolamine, Dilignocelloylphosphatidylethanolamine, Diserotoylphosphatidylethanolamine, Dimontoylphosphatidylethanolamine, Laurooleoylphosphatidylethanolamine, Myristoleoylphosphatidylethanolamine , Palmitoleylphosphatidylethanolamine, dioleoylphosphatidylethanolamine, Ponoylphosphatidylethanolamine, dilinoleoylphosphatidylethanolamine,
- Phosphatidylethanolamine is a safe substance derived from living organisms.
- the cell mouth induction of the present invention It is thought that a Hyde mouth gel is formed by the action.
- Carboxymethylcellulose and phosphatidylethanolamine which are raw materials for the cellulose derivative of the present invention, have 0.1 to 100 equivalents of phosphatidylethanolamine, preferably 0.1 to 0.1 equivalents of carboxyl groups of carboxymethylcellulose. ⁇ React at a rate of 2 to 50 equivalents, more preferably 0.3 to 40 equivalents. 0.1.
- the generated cell mouthpiece # does not form a hyde mouth gel.
- the amount is more than 100 equivalents, the resulting cellulose derivative becomes less hydrophobic and insoluble matter tends to be generated, which is not preferable.
- the condensation reaction between carboxymethylcellulose and phosphatidylethanolamine is the reaction of the catalyst used for the condensation. Depending on the properties and reaction conditions, the reaction efficiency may deteriorate. Therefore, phosphatidylethanolamine should be used i 3 ⁇ 4 more than the calculated value of target S.
- Carboxymethylcellulose and phosphatidylethanolamine are dissolved in water and an organic solvent (A) that is compatible with water, and dissolved in a mixed solvent containing 20 to 70% by volume of water. If the water content is less than 20% by volume, the carboxymethyl cellulose is difficult to dissolve, and if it is more than 70% by volume, the phosphatidylethanolamine solution is difficult to dissolve and the reaction does not proceed.
- the water content is preferably 30 to 60% by volume.
- organic solvent (A) that is compatible with water examples include organic solvents having a cyclic ether bond such as tetrahydrofuran, 1,4-dioxane, 1,3-dioxane, 1,3-dioxolan, and morpholine.
- organic solvents having an amide bond such as dimethylacetamide, dimethylformamide and N-methyl-2-pyrrolidone, amines such as pyridine, piperidine and pyrazine, and sulfoxides such as dimethyl sulfoxide.
- cyclic ethers or sulfoxides are preferable, and tetrahydrofuran, dioxane, and dimethyl sulfoxide are more preferable.
- a carboxyl activator or condensing agent is preferred.
- Carboxyl activators include N-hydroxysuccinimide, p-nitrophenol, N-hydroxybenzotriazol, N-hydroxypiperidine, N-hydroxysuccinamide, 2,4,5-triclonal phenol, N, N-dimethylaminopyridine and the like can be raised.
- the condensing agent m 1-ethyl-3- (dimethylaminopropyl) monocarbodiimide and its hydrochloride, diisopropylcarpoimide, dicyclohexylcarpoimide, N-hydroxy-5-norbornene-2,3-dicarboximide, etc.
- N-hydroxybenzotriazole as the carboxyl activator and 1-edyl 3- (dimethylaminopropyl) monocarbodiimide hydrochloride as the condensing agent (in a narrow sense).
- the reaction temperature is preferably 0 to 60. In order to suppress the production of by-products, it is more preferable to carry out the reaction at 0 to 10.
- the reaction environment is energetic. More preferably, the pH is 6-7.
- carboxymethylcellulose is not substantially dissolved means that the hydroxymethylcellulose sodium salt or carboxymethylcellulose (COOH type) that can be obtained in a powdered or lyophilized state is not hydrolyzed.
- carboxymethylcellulose sodium salt or carboxymethylcellulose (COOH type) that can be obtained in a powdered or lyophilized state is not hydrolyzed.
- solubility of carboxymethylcellulose in an organic solvent it means an organic solvent that hardly dissolves. Specifically, the solubility is 3% or less.
- alcohols such as methanol, ethanol, ⁇ -propyl alcohol, isopropyl alcohol, ⁇ -butyl alcohol, t-butyl alcohol, ethylene glycol, 1,2-propylene glycol, 1,3-propylene
- examples include alcohols such as glycol and glycerin, ketones such as acetone, and aromatic alcohols such as phenol, etc.
- those having a boiling point of less than 100 are preferable, and more preferable.
- the boiling point is 7 3.8 and is as follows:
- methanol, ethanol, and isopropyl alcohol can be used well, but ethanol is preferred when it is used in vivo.
- the organic solvent (B) is added to the cellulose derivative ⁇ : in a mixture of water and organic solvent ( ⁇ ) to form Cellulose invitations may be used.
- a method of adding an organic solvent (B) to a molded body such as a precipitate obtained as described above, a powder in a dry prison state, or a sponge obtained by freeze-drying and washing may be used.
- the catalysts such as the condensing agent and force lpoxyl activator used in the reaction and unreacted phospholipids remaining in the system without reacting.
- methods such as centrifugation and filtration are used. Soxhlet extraction can also be used for cleaning with organic soot (B).
- the cellulose derivative composition of the present invention is prepared by mixing the cellulose derivative obtained by the above-described method and the phospholipid represented by the following formula using water and a mixed ⁇ containing organic soot compatible with water, It can then be done by a method comprising a step of removing soot.
- R 6 and R 7 are each independently an alkyl group or alkenyl group having 9 to 27 carbon atoms
- R 8 is one NH 3 + or one N (CH 3 ) 3 +.
- the phospholipid used in this step is sphatidylethanolamines or phosphatidylcholines.
- R 6 and R 7 are each independently an alkyl group or alkenyl group having 9 to 27 carbon atoms, and R 6 and R 7 are both alkenyl groups having 9 to 19 carbon atoms.
- R 6 CO—and / or R 7 CO—power oleolic groups are particularly preferred, especially R 6 CO— and R 7 CO—power oleoyl groups.
- phospholipids can be used either extracted from animal fibers or synthesized and migrated.
- phosphatidylethanolamines include dilauroyl phosphatidylethanolamine, dimyristoyl phosphatidylethanolamine, dipalmitoylphosphatidylethanolamine, distearoylphosphatidylethanolamine, and diarachidoylphosphatidylethanolamine.
- Dibenoylphosphatidylethanolamine Dilignocelloylphosphatidylethanolamine, Diserotoylphosphatidylethanolamine, Dimontoylphosphatidylethanolamine, Laurooleoylphosphatidylethanolamine, Myristole Oil phosphatidylethanolamis palmito oleoyl phosphatidylethanolamine, dioleoylphosphatidylethanolamine, jinel Nylphosphatidylethanolamine, dilinoleol phosphatidylethanolamine, dilinolenoylphosphatidylethanolamine, dihilagonoylphosphatidylethanolamine, diaradonolphosphatidylethanolamine, didocosahexaenoyl It is possible to mention Ruphosphatidylethanolamine.
- phosphatidylcholines examples include dilauroyl phosphatidylcholine, dimyristoyl phosphatidylcholine, dipalmitoyl phosphatidylcholine, distearoylphosphine.
- oleoylphosphatidylethanolamine oleoylphosphatidyl / corinka are preferred.
- Such cellulose attraction and phospholipid are mixed in a mixed solvent of water and an organic solvent (A) that is compatible with water.
- a mixed solvent having a water content of 20 to 70% by volume preferably a mixed solvent having a content of ⁇ of 30 to 60% by volume.
- organic rice cake ( ⁇ ) it can be used for the organic difficulty mentioned above.
- cyclic ethers or sulfoxides are preferred, and tetrahydrofuran, dioxane, and dimethyl sulfoxide are more preferred.
- the mixing ratio of the cell mouth derivative and the phospholipid is such that the molar equivalent ratio of the cellulose-induced repeating unit and the molar equivalent ratio of the phospholipid is 1: 0.0 5-1: 1, 1: Q.;! To 1: 0.8, more preferably 1: 0.1 to 5: 1: 0.6. If the phospholipid mole St is lower than 0.05, the effect of improving viscoelasticity will not be obtained, and if it exceeds 1, the phospholipid will be reversed, and the effect of improving viscoelasticity will be difficult. .
- the temperature may be 0 to 30 and preferably 10 to 25 t. Further, the contents of the polymer and phospholipid in the solvent are not particularly limited, but the total is preferably 3% by weight or less.
- the organic solvent (A) is removed to obtain the desired sincerity.
- the dialysis membrane is not particularly limited, but a commercially available Visking tube (regenerated cellulose membrane) can be preferably used.
- the anti-adhesion material of the present invention is a hide-mouthed gel containing the cellulose derivative of the present invention, and the cellulose attraction of the present invention is 0.:! To 5.0 parts by weight, preferably 100 parts by weight of water. Hyde mouth gel containing 0.2 to 2.0 parts by weight, more preferably 0.3 to 1.0 parts by weight.
- the preferred complex elastic modulus of the gel and gel is as follows: when measured at an angular velocity of 10 rad / sec using a dynamic viscoelasticity measuring device under the conditions that the polymer concentration in water is 1% by weight and the temperature is 37. Those having 5 0 to 90 O NZm 2 are preferred, and those having 1 0 0 to 70 0 N / m 2 are more preferred. This is because it is the easiest to handle as this range force type gel.
- the hide-mouthed gel of the present invention is colorless and transparent, and it is possible to detect foreign matters such as dust in the manufacturing process, which is advantageous for industrial production.
- Hyde Mouth Gel Water contained in Hyde Mouth Gel!
- Other components of ⁇ include condensing agents used as catalysts, by-products such as urea produced when the condensing agent undergoes a predetermined chemical reaction, carboxyl activators, and unreacted phosphatidylethanolamines.
- Foreign substances that may be mixed in each stage of the reaction, ions used for pH adjustment, etc. are included, but these components can be purified or washed with the above organic solvent (B). It is recommended that all compounds be kept at a low level and not recognized as a foreign body reaction when placed in vivo.
- the cellulose derivative composition of the present invention can form an id mouth gel.
- a hyde mouth gel having appropriate viscoelasticity can be obtained.
- Hyde Mouth Gels are viscoelastic enough that they will not flow down even if the container containing Hyde Mouth Gel is tilted, and can be easily deformed when touched with an S spatula such as a spatula. It is easy to apply to the affected area. It is also possible to inject with a small tube such as a syringe.
- a preferable complex elastic modulus of such a gel is 50 0 when measured at an angle of 3 ⁇ 4 S 10 rad / sec using a dynamic viscoelasticity measuring device under conditions of a polymer concentration in water of 1% by weight and a temperature of 37.
- Those with ⁇ 90 0 ON / m 2 are preferred, and those with 100 0 70 0 N / m 2 are more preferred. This is because this range force is most easily handled as a ⁇ type gel.
- the water, cellulose attraction and phospholipid components contained in the Hyde Mouth Gel include condensing agents used as a catalyst, by-products such as urea produced by the condensing agent via a predetermined chemical reaction, carboxyl Examples include activators, foreign substances that may be introduced at each stage of the reaction, and ions used to adjust ⁇ . Any compound is preferably ⁇ which is suppressed to a low level so that it is not recognized as a foreign body reaction when placed in a living body.
- Cellulose derivatives, cellulose derivative compositions, and hide-mouth gels of the present invention can be used for medical applications including medical materials, daily necessities such as hair care products and skin moisturizers, and cosmetic applications. Is possible. Since this gel can be injected through a syringe, it is particularly powerful for use in minimally invasive medical applications, and it retains and gradually maintains humoral factors such as cell carriers and growth factors for regenerative medicine. It can be preferably used as a carrier to be released, a carrier to hold a compound that can be used as a medicine, a carrier to be slowly released, a medical material such as an adhesion preventive material, and particularly an injection-type adhesion preventive material.
- an adhesion preventive material such as an adhesion preventive material
- injection-type adhesion preventive material such as an adhesion preventive material
- CMCNa Carboxymethylcellulose sodium (Japan »Chemical Co., substitution degree 0.69),
- HOB t ⁇ H 2 0 1-Hyd roxybenzo tri azo le, mo nohyd ra te (Synthetic Organic Organisation ⁇ ff ⁇ M),
- the proportion of phospholipid in the cellulose derivative was determined by analyzing the total phosphorus content by the vanadmolybdate M3 ⁇ 4S method. '(3) Measurement of complex elastic modulus of Hyde mouth gel
- the complex elastic modulus of the Hyde mouth gel was measured at 37 and at an angle of 3 ⁇ 43 ⁇ 410 radZsec using Rheometer RFIII (TAInstrument), a dynamic viscoelasticity measuring device.
- the complex elastic modulus is a constant representing the ratio of stress and strain of an elastic body.
- CMCNa 20 Omg with an average liver mass of 2.3 million was dissolved in 40 ml of water, and tetrahydrofuran 4 Oml was further added.
- L ⁇ ⁇ -dioleoylphosphatidylethanolamine 169.7 mg (0.000228mo 1) (100 equivalents of the carboxyl group of CMCN a, 40 tons, EDC48 mg (0.00025 lmo 1), HOB t ⁇ ⁇ 2 038. 4 mg (0. 00025 lmo 1) was dissolved in 10 ml 1 of tetrahydrofuran / water 1/1 and added to the reaction system, followed by overnight dripping.
- a hydrogel having a concentration of 1% by weight was prepared by dissolving 1 Omg of the cellulose-dried composition after drying in 99 Omg of ion-exchanged water.
- the complex elastic modulus of the obtained hydrogel was measured and found to be 188.3 N / m 2 .
- the ratio of the molar equivalent of repeating units in the cellulose derivative to the molar equivalent of L- ⁇ -dilauroylphosphatidylcholine is 1: 0.27.
- L- ⁇ -dilauroylphosphatidylcholine 22.5 mg (0.036 mmo 1 ) was applied in the same manner as in Example 6 except that a cellulose derivative was obtained, and then a hide-mouthed gel was prepared. As a result of measuring the complex elastic modulus of the resulting hide-mouthed gel, it was 249. lN / m 2 .
- Example 8 The ratio of the molar equivalent of repeating units in the cellulose derivative to the molar equivalent of L- ⁇ -dilauroylphosphatidylcholine is 1: 0.27.
- L- ⁇ -dilauroylphosphatidylcholine 22.5 mg (0.036 mmo 1 ) was applied in the same manner as in Example 6 except that a cellulose derivative was obtained, and then a hide-mouthed
- L- ⁇ -distearoylphosphatidylcholine 28.8 mg (0.27) so that the ratio of the molar equivalents of repeating units in the cellulose derivative to the molar equivalent of L- ⁇ -distearoylphosphatidylcholine is 1: 0.27.
- the same operation as in Example 6 was performed except that 036 mmo 1) was applied Pf. After obtaining the cellulose repellent, a hide-mouthed gel was prepared. As a result of measuring the complex elastic modulus of the resulting hide-mouthed gel, it was 261.2 NZm 2 . Difficult example 11]
- the ratio of the molar equivalents of repeating units in the cellulose derivative to the molar equivalents of L- ⁇ -dilauroylphosphatidyltanolamine is 1: 0.2.
- L- ⁇ -Dilauroylphosphatidylethanolamine 20 After adding 9 mg (0. 036 mmo 1) to P "T, the same operation as in Example 6 was carried out to obtain a cellulose-triggered product, and then a hide-mouthed gel was prepared. Complexity of the obtained hydrogel As a result of measuring the elastic modulus, it was 212.7 N / m 2 Example 12]
- the cellulose derivative composition hide-mouth gel of Example 1 was dropped on a Petri dish coated with nitrocellulose, and then air-dried for 6 hours. Next, 30 / gZ After coating 3 ml ⁇ fibronectin Petri dish, the Petri dish was washed with PBS ( Figure 1). Finally, the murine NIHZ3T3i1 ⁇ 2 blasts suspension 5ml of 0. 4X10 5 cells Zml were plated on the entire petri dish (2X10 5 cells / Petri dish). Using a phase-contrast microscope, cell adhesion to the gel mouth was observed for 7 days. As a result, cell adhesion and scum were not observed on the cellulose-derivatized eight-sided gel.
- Example 12 Using the hydrated gel of Example 2 in place of the cellulose derivative composition hydrated gel of ⁇ , the same operation as in Example 12 was carried out to evaluate cell adhesion to the hydrated gel and U sleep. The result was almost the same as Example 12.
- Example 3 Use the hydrogel of Example 3 in place of the cellulose derivative composition hydrogel of Example 1. J3 ⁇ 4 ⁇ Perform the same operation as in Example 12 to evaluate the cell adhesion and moisture to the Hyde mouth gel. did. The result was almost the same as Example 12. Ordinance 15]
- Example 12 Using the hydrogel of Example 5 in place of the cellulose derivative composition hydrogel of Example 1, the same procedure as in Example 12 was performed to evaluate the cell density and the moisture on the hide-mouthed gel. The result was almost the same as Example 12.
- Example 16 Cell adhesion to fibronectin and t / S moisture were evaluated in the same manner as in Example 12 except that 30 g / m1 fibronectin was used instead of the hydose mouth gel of the cellulose derivative composition of Example 1. .
- the cells were observed to spread throughout fibronectin.
- mouse NIHZ3T3 bud cells were adhered and infiltrated in Comparative Example 1 compared to mouse NIHZ3T3 bud cells in Examples 12, 13, 14, and 15. Almost no adhesion or infiltration to the hydrogel of the invention was observed, and the cells selectively adhered to the fibronectin regions that were not coated with hydrogen. From the above, it was confirmed that the Hyde Mouth Gels in Examples 12, 13, 14, and 15 had an effect of suppressing cell moisture.
- Example 16 Example 16
- Example 1 Thereafter, the cellulose derivative octahydrogel (1 ml) of Example 1 was applied to the defect site of the abdominal wall, the muscle layers of the incision were joined together, and the skin was sutured with 4 to 5 needles. Kura ijf recruitment department was disinfected with isodine disinfectant and then returned to the cage. After 4 weeks of model preparation, the animals were laparotomized under pentobarbi anesthesia under Lunatrium anesthesia, and the degree of intraperitoneal adhesion was observed macroscopically and scored according to the criteria shown below. A control to which no cellulose derivative eight-gel was applied was used as a control.
- Score 1 A state of weak adhesion that can be broken by mild traction
- Example 17 Using 9 rats, the same procedure as in Example 17 was performed, except that the Hyde Mouth Gel of Example 2 was used in place of the Cellulose Derivative Composition Eight Mouth Gel of Example 1. The degree and the effect on the intensity hurt. As a result, the adhesion score and strength were 0.2 soil 0.7 and 50 ⁇ 149 grams (average soil standard deviation), respectively.
- Example 17 As a control, the same operation as in Example 17 was performed without applying zo and id mouth gel, and the degree of adhesion and strength were evaluated. As a result, the adhesion score and strength were 2.0 ⁇ 1.3 and 3 97 ⁇ 313 grams (mean soil standard deviation), respectively.
- the cellulose attractant hydrogel of the present invention obtained in Examples 2, 3, and 5 has an effect of strongly suppressing adhesion in vivo, and the effect of adhesion after surgery is effective. It was shown that it can be prevented.
- Example 2 Using the cellulose-derived hydrogel of Example 1 with different separation and application amounts, the same operation as in Examples 16 and 17 was performed, and the effect on the degree of adhesion and strength of the throat gel was evaluated. Nine rats in each group were used. The results are shown in Table 2. Table 2
- CMCNa a cellulose derivative prepared by the same procedure as in Example 1 except that a molecular weight of 970,000 was used as CMCNa (separated 0.001; expressed as “CMC-PE”) was dissolved in a sodium chloride aqueous solution and gelled. Viscosity (E ta (P), value at 1 Orad / sec) was measured. The results are shown in Table 3. The concentration of the polymer is 1% by weight, “CMC—Na” represents carboxymethyl cellulose sodium salt having a molecular weight of 970,000 used as a raw material, and PBS represents phosphate buffered saline (0.9% NaC 1). Table 3
- the cellulose derivative eight-sided gel of the present invention surprisingly increases its viscosity rapidly when coexisting with a small amount of sodium chloride.
- the injection is facilitated by reducing the viscosity without adding sodium chloride. Touching to increase the concentration of sodium chloride will increase the viscosity, making it easier to perform the desired functions such as anti-adhesion agents.
- the present inventors have developed a cellulose derivative according to the present invention: Hachidrogeli cellulose derivative ## Composition Hydrate Gel, and other polysaccharides are modified with a group having an amino group! (We examined the effect of increasing viscoelasticity due to TT. For example, hyaluronic acid with leucine methyl ester, tyrosine ethyl ester, phenylalanine methyl ester, vitamin ⁇ 5, carbachol (carbamylcholine chloride), edylamine, and nicotinamide.
- the present inventors have found that by modifying carboxymethylcellulose with alkylamine, specifically, oleylamine, a highly viscoelastic cellulose-induced octahydrogel can be obtained.
- alkylamine specifically, oleylamine
- a highly viscoelastic cellulose-induced octahydrogel can be obtained.
- the effect of suppressing the cell adhesion and infiltration of the CMC-alkylamine hydrogel was low. It has been found that the high viscoelasticity of the hydrogel necessarily leads to a good anti-adhesion effect.
- CMCN a (Nippon Seika Chemical Co., Ltd., F 15 MHC, substitution degree 0.77) was used, and phospholipids were dilauroyl phosphatidylethanolamine (COAT SOME ME—20 20 20 »Fat Co., Ltd. was used.
- the other reagents were the same as those described in Example 1.
- CMCNa 1 g was dissolved in 50 ml of water, and 20 mg of dilauroyl phosphatidylethanolamine was added to this solution, followed by stirring at room temperature for 1 hour. £ 500 was added to this «and won overnight at room temperature.
- the resulting fibers were dialyzed against deionized water and dried.
- the obtained lyophilized product was mixed with water so that the polymer concentration was 1% by weight, and viscoelasticity was measured.
- the complex elastic modulus of CMCN a before the reaction was 0.4 N / m 2
- the complex elastic modulus of the obtained lyophilized product was 0.4 N / m 2.
- the obtained mixture of cellulose derivative and water remained as a fluid that flowed down when the container was tilted, and showed no gel properties.
- the cellulose derivative composition of the present invention is useful as a medical hyde mouth gel, particularly as an injectable anti-adhesive material.
- the anti-adhesion material can be used in a course on the spine, joints, tendons, and columns in order to prevent adhesion of damaged biological surfaces. More specifically, in spinal surgery, adhesion can be prevented by applying, for example, the adhesion preventing material of the present invention to isolate the dura mater from the nerve root periphery. When adhesion occurs, it is necessary to perform adhesion peeling for the purpose of securing a movable area.
- the anti-healing material of the present invention it is possible to prevent adhesion, avoid re-generation, improve medical economy, and improve the quality of life of patients.
- Adhesion can be prevented by applying the anti-adhesion material of the present invention to the aftergrown granule I ⁇ site.
- the anti-adhesion material of the present invention has excellent retention in the body and is useful as an anti-adhesion material.
- the anti-adhesion material is a gel, it can be applied to a part having a complicated shape, and can be easily applied using an endoscope.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Surgery (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08711228.0A EP2112170A4 (en) | 2007-02-06 | 2008-02-06 | CELLULOSE DERIVATIVE AND MANUFACTURING METHOD THEREFOR |
KR1020097018338A KR20090109120A (ko) | 2007-02-06 | 2008-02-06 | 셀룰로오스 유도체 및 그 제조 방법 |
CN2008800042878A CN101605817B (zh) | 2007-02-06 | 2008-02-06 | 纤维素衍生物及其制备方法 |
CA2676300A CA2676300C (en) | 2007-02-06 | 2008-02-06 | Cellulose derivative and method for production thereof |
AU2008213323A AU2008213323B2 (en) | 2007-02-06 | 2008-02-06 | Cellulose derivative and method for production thereof |
JP2008557189A JP5059787B2 (ja) | 2007-02-06 | 2008-02-06 | セルロース誘導体およびその製造方法 |
US12/525,464 US8455001B2 (en) | 2007-02-06 | 2008-02-06 | Cellulose derivative and method for production thereof |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007026514 | 2007-02-06 | ||
JP2007-026514 | 2007-02-06 | ||
JP2007-026515 | 2007-02-06 | ||
JP2007026515 | 2007-02-06 | ||
JP2007098447 | 2007-04-04 | ||
JP2007-098447 | 2007-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008096894A1 true WO2008096894A1 (ja) | 2008-08-14 |
Family
ID=39681787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/052382 WO2008096894A1 (ja) | 2007-02-06 | 2008-02-06 | セルロース誘導体およびその製造方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US8455001B2 (ja) |
EP (1) | EP2112170A4 (ja) |
JP (1) | JP5059787B2 (ja) |
KR (1) | KR20090109120A (ja) |
CN (1) | CN101605817B (ja) |
AU (1) | AU2008213323B2 (ja) |
CA (1) | CA2676300C (ja) |
WO (1) | WO2008096894A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011132800A1 (ja) * | 2010-04-22 | 2011-10-27 | 帝人株式会社 | ハイドロゲル |
US20110301121A1 (en) * | 2009-02-19 | 2011-12-08 | University Nagoya National University Corporation | Hydrogel of polysaccharide derivative |
WO2018008700A1 (ja) * | 2016-07-07 | 2018-01-11 | 日本製紙株式会社 | 変性セルロースナノファイバーおよびこれを含むゴム組成物 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8668863B2 (en) | 2008-02-26 | 2014-03-11 | Board Of Regents, The University Of Texas System | Dendritic macroporous hydrogels prepared by crystal templating |
US9095558B2 (en) | 2010-10-08 | 2015-08-04 | Board Of Regents, The University Of Texas System | Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications |
WO2012048283A1 (en) | 2010-10-08 | 2012-04-12 | Board Of Regents, The University Of Texas System | One-step processing of hydrogels for mechanically robust and chemically desired features |
US11565027B2 (en) | 2012-12-11 | 2023-01-31 | Board Of Regents, The University Of Texas System | Hydrogel membrane for adhesion prevention |
US10590257B2 (en) | 2016-09-26 | 2020-03-17 | The Board Of Trustees Of The Leland Stanford Junior University | Biomimetic, moldable, self-assembled cellulose silica-based trimeric hydrogels and their use as viscosity modifying carriers in industrial applications |
EP3577271B1 (en) * | 2017-02-01 | 2024-09-04 | Aalto University Foundation SR | A method to convert mechanical pulp derived waste material into value added cellulose products |
WO2018165327A1 (en) | 2017-03-08 | 2018-09-13 | Alafair Biosciences, Inc. | Hydrogel medium for the storage and preservation of tissue |
US11975123B2 (en) | 2018-04-02 | 2024-05-07 | The Board Of Trustees Of The Leland Stanford Junior University | Adhesion prevention with shear-thinning polymeric hydrogels |
US11969526B2 (en) | 2017-04-03 | 2024-04-30 | The Board Of Trustees Of The Leland Stanford Junior University | Adhesion prevention with shear-thinning polymeric hydrogels |
CN110804104B (zh) * | 2019-10-30 | 2021-12-07 | 暨南大学 | 一种细胞膜仿生表面改性细菌纤维素及其制备方法与应用 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01301624A (ja) | 1988-05-31 | 1989-12-05 | Nippon Zeon Co Ltd | 癒着防止材 |
JPH0270703A (ja) * | 1987-10-23 | 1990-03-09 | Yissum Res Dev Co Of Hebrew Univ Of Jerusalem | ホスホリパーゼa↓2阻害組成物およびその使用 |
WO1992000105A1 (en) | 1990-06-25 | 1992-01-09 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
WO1992020349A1 (en) | 1991-05-20 | 1992-11-26 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
JPH09296005A (ja) | 1996-04-26 | 1997-11-18 | Kuraray Co Ltd | 癒着防止材 |
WO2001046265A1 (en) | 1999-12-22 | 2001-06-28 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
JP2003528026A (ja) * | 1998-05-13 | 2003-09-24 | エムエル・ラボラトリーズ・パブリック・リミテッド・カンパニー | 外科手術上の癒着を阻止するためのデキストリンを含有する組成物 |
JP2005508827A (ja) * | 2000-01-10 | 2005-04-07 | イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム | 疾患の治療における脂質コンジュゲートの使用 |
JP2006296916A (ja) | 2005-04-25 | 2006-11-02 | Teijin Ltd | 癒着防止材 |
WO2007015579A1 (ja) * | 2005-08-04 | 2007-02-08 | Teijin Limited | セルロース誘導体 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366755A (en) * | 1989-02-10 | 1994-11-22 | Maritta Timonen | Foodstuffs containing novel degraded cellulose derivatives |
WO2005000374A1 (ja) | 2003-06-30 | 2005-01-06 | Denki Kagaku Kogyo Kabushiki Kaisha | 脊椎・脊髄手術用癒着防止材 |
-
2008
- 2008-02-06 EP EP08711228.0A patent/EP2112170A4/en not_active Withdrawn
- 2008-02-06 JP JP2008557189A patent/JP5059787B2/ja not_active Expired - Fee Related
- 2008-02-06 AU AU2008213323A patent/AU2008213323B2/en not_active Ceased
- 2008-02-06 KR KR1020097018338A patent/KR20090109120A/ko not_active Application Discontinuation
- 2008-02-06 CA CA2676300A patent/CA2676300C/en not_active Expired - Fee Related
- 2008-02-06 US US12/525,464 patent/US8455001B2/en not_active Expired - Fee Related
- 2008-02-06 WO PCT/JP2008/052382 patent/WO2008096894A1/ja active Application Filing
- 2008-02-06 CN CN2008800042878A patent/CN101605817B/zh not_active Expired - Fee Related
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0270703A (ja) * | 1987-10-23 | 1990-03-09 | Yissum Res Dev Co Of Hebrew Univ Of Jerusalem | ホスホリパーゼa↓2阻害組成物およびその使用 |
US5064817A (en) | 1987-10-23 | 1991-11-12 | Yissum Research Development Company Of Hebrew University Of Jerusalem | Phospholipase a2 inhibiting compositions and their use |
JPH01301624A (ja) | 1988-05-31 | 1989-12-05 | Nippon Zeon Co Ltd | 癒着防止材 |
WO1992000105A1 (en) | 1990-06-25 | 1992-01-09 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
WO1992020349A1 (en) | 1991-05-20 | 1992-11-26 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
JPH09296005A (ja) | 1996-04-26 | 1997-11-18 | Kuraray Co Ltd | 癒着防止材 |
JP2003528026A (ja) * | 1998-05-13 | 2003-09-24 | エムエル・ラボラトリーズ・パブリック・リミテッド・カンパニー | 外科手術上の癒着を阻止するためのデキストリンを含有する組成物 |
WO2001046265A1 (en) | 1999-12-22 | 2001-06-28 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
JP2005508827A (ja) * | 2000-01-10 | 2005-04-07 | イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム | 疾患の治療における脂質コンジュゲートの使用 |
JP2006296916A (ja) | 2005-04-25 | 2006-11-02 | Teijin Ltd | 癒着防止材 |
WO2007015579A1 (ja) * | 2005-08-04 | 2007-02-08 | Teijin Limited | セルロース誘導体 |
Non-Patent Citations (4)
Title |
---|
AM. J. SURG., vol. 169, 1995, pages 154 - 159 |
BUCKENMAIER CC 3RD ET AL., AM SURG., vol. 65, no. 3, 1999, pages 274 - 82 |
See also references of EP2112170A4 |
SNOW DM ET AL., EXP. NEUROL, vol. 109, no. 1, 1990, pages 111 - 30 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110301121A1 (en) * | 2009-02-19 | 2011-12-08 | University Nagoya National University Corporation | Hydrogel of polysaccharide derivative |
WO2011132800A1 (ja) * | 2010-04-22 | 2011-10-27 | 帝人株式会社 | ハイドロゲル |
AU2011243517B2 (en) * | 2010-04-22 | 2014-02-13 | Teijin Limited | Hydrogel |
JP5542200B2 (ja) * | 2010-04-22 | 2014-07-09 | 帝人株式会社 | ハイドロゲル |
WO2018008700A1 (ja) * | 2016-07-07 | 2018-01-11 | 日本製紙株式会社 | 変性セルロースナノファイバーおよびこれを含むゴム組成物 |
JP6276489B1 (ja) * | 2016-07-07 | 2018-02-07 | 日本製紙株式会社 | 変性セルロースナノファイバーおよびこれを含むゴム組成物 |
US11261302B2 (en) | 2016-07-07 | 2022-03-01 | Nippon Paper Industries Co., Ltd. | Modified cellulose nanofiber and rubber composition including the same |
Also Published As
Publication number | Publication date |
---|---|
JP5059787B2 (ja) | 2012-10-31 |
EP2112170A1 (en) | 2009-10-28 |
JPWO2008096894A1 (ja) | 2010-05-27 |
CN101605817B (zh) | 2013-03-27 |
US8455001B2 (en) | 2013-06-04 |
AU2008213323A1 (en) | 2008-08-14 |
US20100129452A1 (en) | 2010-05-27 |
KR20090109120A (ko) | 2009-10-19 |
AU2008213323B2 (en) | 2012-05-24 |
EP2112170A4 (en) | 2013-06-19 |
CA2676300A1 (en) | 2008-08-14 |
CN101605817A (zh) | 2009-12-16 |
CA2676300C (en) | 2014-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008096894A1 (ja) | セルロース誘導体およびその製造方法 | |
Jayakumar et al. | Novel carboxymethyl derivatives of chitin and chitosan materials and their biomedical applications | |
JP4993465B2 (ja) | 変性された高分子ならびにその製造方法および使用方法 | |
JP4795539B2 (ja) | 細胞増殖性疾患を治療するための方法および組成物 | |
Li et al. | Cytotoxicity and biocompatibility evaluation of N, O-carboxymethyl chitosan/oxidized alginate hydrogel for drug delivery application | |
JP3425147B2 (ja) | ポリアニオン性多糖の非水溶性誘導体 | |
EP1794192B1 (en) | Photoreactive polysaccharide, photocrosslinked polysaccharide products, the method of making them and medical materials made therefrom | |
JP2004507586A (ja) | 過カルボン酸エステル化された多糖類、及びそれらの作製方法 | |
WO2007015579A1 (ja) | セルロース誘導体 | |
WO2009078492A1 (ja) | セルロース誘導体およびそのハイドロゲル | |
CN105801870B (zh) | 一种聚唾液酸-透明质酸复合凝胶的制备方法及所得产品和应用 | |
JP2010209130A (ja) | アルギン酸誘導体およびその製造方法 | |
JP2014528406A (ja) | 治療薬を送達するための多層インプラント | |
Brekke et al. | Hyaluronan as a biomaterial | |
WO2016075977A1 (ja) | 自己組織化ペプチド修飾キトサンナノ会合体の合成とプロテインデリバリーへの応用 | |
JP2010035744A (ja) | 癒着防止材 | |
Rahaman et al. | Chitin and Chitosan and Their Polymers | |
WO2001012675A1 (fr) | Derives de glycosaminoglycane et leur utilisation | |
RU2455007C1 (ru) | Способ получения гелеобразующих фосфатов декстрана |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880004287.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08711228 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2008557189 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2676300 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008213323 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12525464 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008711228 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2009130351 Country of ref document: RU Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2008213323 Country of ref document: AU Date of ref document: 20080206 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097018338 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 5185/CHENP/2009 Country of ref document: IN |